Vice President, AI Enablement

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so. Does this inspire you and feel like a fit? Then we would love to have you join us! Vice President, Head of AI Center of Excellence (COE) The Role The Vice President, Head of AI Center of Excellence will lead Genmab’s enterprise AI strategy and its execution across Research, Development, Commercial, and enterprise functions. The role will be accountable for converting advances in AI into measurable scientific, operational, and business value. This includes building AI solutions with Genmab teams, establishing responsible governance, managing strategic AI partnerships, and creating the capabilities required for Genmab to maximize the value of AI throughout the whole value chain. The successful candidate will combine enterprise leadership, technical credibility, business judgment, and the ability to drive change across scientific, regulated, and corporate environments. Work arrangement: This role offers flexibility to work away from the office for 20%–40% of a typical schedule. Employees may use this work schedule in increments of single days or multiple consecutive days, provided it does not exceed 40% within a 60-day period, and is approved by the hiring manager. Key Responsibilities

• Define and execute Genmab’s enterprise AI strategy, roadmap, operating model, and investment priorities.
• Lead the AI Center of Excellence, including forward-deployed AI engineering, AI governance, and strategic AI partnerships.
• Work with functional leaders to identify and prioritize high-value AI opportunities across the company.
• Ensure AI initiatives move rapidly from experimentation to adoption, scaled deployment, and measurable impact.
• Establish a portfolio-management approach that balances near-term value, strategic capability building, and longer-term innovation.
• Build reusable AI platforms, products, engineering patterns, and governance pathways that reduce duplication and accelerate delivery.
• Ensure AI solutions meet appropriate standards for security, privacy, quality, reliability, validation, and responsible use.
• Lead strategic relationships with foundation-model providers, technology companies, and implementation partners.
• Advise the Executive Committee and other senior leaders on AI opportunities, investments, risks, and market developments.
• Develop AI talent, strengthen enterprise AI literacy, and create a culture of responsible experimentation and adoption.
• Define and track measures for adoption, business value, scientific impact, delivery speed, cost, risk, and capability maturity.

Qualifications

• A bachelor’s degree is required; An advanced scientific, and/or technical degree is highly preferred.
• 15+ years of leadership experience in artificial intelligence, data science, software engineering, digital transformation, or technology strategy.
• Demonstrated success building and scaling AI capabilities in a complex enterprise.
• Strong understanding of generative AI, foundation models, AI agents, machine learning, data platforms, and modern software development.
• Experience translating emerging technologies into deployed products and measurable business outcomes.
• Experience in pharmaceuticals, biotechnology, healthcare, or another highly regulated industry is strongly preferred.
• Ability to operate effectively across scientific, clinical, commercial, technology, quality, legal, and executive stakeholders.
• Strong people leadership, strategic judgment, communication, and change-management skills.

For US based candidates, the proposed salary band for this position is as follows: $277,280.00---$415,920.00 The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives. When You Join Genmab, You’re Joining a Culture That Supports Your Physical, Financial, Social, And Emotional Wellness. Within The First Year, Regular Full-time U.S. Employees Are Eligible For

• 401(k) Plan: 100% match on the first 6% of contributions
• Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
• Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
• Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
• Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
• Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses

Further details on eligibility for compensation and benefits based on role will be provided during the recruitment process About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X. Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com). Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.